FDA Confirms Ron Farkas No Longer at FDA (SRPT) - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
FDA Confirms Ron Farkas No Longer at FDA (Nasdaq: SRPT) - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta's (SRPT) Exondys 51 covered by Humana (HUM) with prior authorization - Bloomberg
- Stocks with Implied Volatility Movement
- Sarepta Therapeutics (SRPT) Target of Cautious Article
Create E-mail Alert Related CategoriesFDA, Hot FDA News, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!